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ABSTRACT 22 
Hyperglycemia, commonly present after a meal, causes transient impairment in endothelial 23 
function. We examined whether increases in blood flow (BF) protect against the hyperglycemia-24 
mediated decrease in endothelial function in healthy subjects and patients with type 2 diabetes 25 
mellitus (T2DM). Ten healthy subjects and 10 age- and sex-matched T2DM patients underwent 26 
simultaneous bilateral assessment of brachial artery endothelial function by means of flow-27 
mediated dilation (FMD), using high-resolution echo-Doppler. FMD was examined before and 28 
60, 120 and 150 minutes after a 75-gr oral glucose challenge. We unilaterally manipulated BF by 29 
heating one arm between minute 30 and 60. Oral glucose administration caused a statistically 30 
significant, transient increase in blood glucose in both groups (P<0.001). Forearm skin 31 
temperature, brachial artery BF and shear rate significantly increased in the heated arm 32 
(P<0.001), and to a greater extent compared to the non-heated arm in both groups (interaction-33 
effect, P<0.001). The glucose load caused a transient decrease in FMD% (P<0.05), whilst 34 
heating significantly prevented the decline (interaction-effect: P<0.01). Also when correcting for 35 
changes in diameter and shear rate, we found that the hyperglycemia-induced decrease in FMD 36 
can be prevented by local heating (P<0.05). These effects on FMD were observed in both groups. 37 
Our data indicate that non-metabolically driven elevation in BF and shear rate can similarly 38 
prevent the hyperglycemia-induced decline in conduit artery endothelial function in healthy 39 
volunteers and in patients with type 2 diabetes. Additional research is warranted to confirm that 40 
other interventions increasing BF and shear rate equally protect the endothelium when 41 
challenged by hyperglycemia. 42 
KEYWORDS: cardiovascular risk; flow mediated dilation; hyperglycemia; endothelial function; 43 
shear rate; blood flow  44 
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INTRODUCTION  45 
Type 2 diabetes mellitus (T2DM) affects approximately 200 million people worldwide (46). 46 
Whilst the inability to maintain appropriate glucose levels plays a central role in the etiology of 47 
T2DM, mortality and morbidity in T2DM is largely related to the presence of cardiovascular 48 
diseases and vascular complications (9, 10). In developing cardiovascular complications, the 49 
presence of endothelial dysfunction plays a major role (24, 25). Various stimuli are identified 50 
that potentially alter endothelial (dys)function (23, 28). For example, increased blood glucose 51 
levels or hyperglycemia, which is frequently present in T2DM despite optimal pharmacological 52 
treatment (8), induces a transient impairment in endothelial function (1, 16, 17, 33, 43, 47). The 53 
detrimental impact of hyperglycemia on endothelial function has been found in several studies in 54 
healthy adults (1, 33, 43, 47) as well as in patients with T2DM (16, 20). Given the frequent 55 
exposure to hyperglycemia, these observations highlight the importance for strategies to prevent 56 
or attenuate the impact of hyperglycemia on endothelial function. 57 
 58 
Studies in animals (22, 44) and humans (11) suggest that elevation in shear rate, i.e. the frictional 59 
force of blood upon the arterial wall, leads to improvements in vascular function and structure. A 60 
recent series of studies in humans demonstrated that elevation in shear rate, induced by heating 61 
of a forearm, can acutely (42) and chronically (27) improve vascular function. Moreover, we 62 
recently found that increases in shear rate (via heating of the forearm) prevents the immediate 63 
decline in brachial artery endothelial function during activation of the sympathetic nervous 64 
system (39). In line with these recent observations, elevation in shear rate may prevent the 65 
hyperglycemia-induced decline in endothelial function in healthy volunteers and in T2DM. 66 
 67 
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The primary objective of this study, therefore, was to examine whether increases in shear rate 68 
(through heating of the skin) protect against the transient hyperglycemia-mediated decrease in 69 
endothelial function in healthy subjects and patients with T2DM. For this purpose, we bilaterally 70 
examined brachial artery flow mediated dilation (FMD) as a measure for endothelial function 71 
before and after a 75-gr glucose load, which is demonstrated to cause marked elevations in blood 72 
glucose and a transient decrease in endothelial function (1, 16, 20, 33, 43, 47). In addition, we 73 
unilaterally manipulated shear rate in the brachial artery by heating the arm for 30-minutes, to 74 
examine the hypothesis that (non-metabolically driven) increases in shear rate prevent the 75 
decline in endothelial function.  76 
 77 
 78 
METHODS 79 
Participants 80 
Ten male subjects with T2DM (age 63 ± 6 years) and 10 age-matched healthy male controls (57 81 
± 9 years) were included in our study. Individuals were excluded if they smoked, had past or 82 
present cardiovascular disease, hypercholesterolemia or hypertension (>160 mmHg systolic 83 
and/or >90 mmHg diastolic pressure). The subjects in the T2DM group had to be diagnosed with 84 
type 2 diabetes mellitus at least two years ago. Subjects in this group were excluded if they had 85 
vascular complications due to type 2 diabetes mellitus (e.g. diabetic foot ulcer). All participants 86 
provided written informed consent before participation. The study procedures were approved by 87 
the medical ethics committee of the region Arnhem-Nijmegen, the Netherlands and adhered to 88 
the Declaration of Helsinki (2000). This study is registered at the Netherlands Trial Registry as 89 
NTR4631. 90 
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 91 
Experimental Design 92 
In this study, both groups reported to our laboratory once for assessment of glucose homeostasis 93 
and brachial artery endothelial function. First, we performed simultaneous, bilateral assessment 94 
of brachial artery FMD, immediately followed by the ingestion of 75-gr of glucose dissolved in 95 
200 mL water. Thirty minutes after ingestion, we unilaterally heated one forearm for 30 minutes. 96 
Heating of the arm was randomized between subjects. Subsequently, bilateral simultaneous 97 
assessment of brachial artery FMD was repeated at 60, 120 and 150 minutes after ingestion of 98 
the glucose load. 99 
 100 
Experimental Measures 101 
Ultrasound assessments were performed in a quiet temperature-controlled room (22°C). 102 
Measurements in a single arm were always performed by the same sonographer for each 103 
individual subject. All measurements were performed following a ≥6 hour fast, ≥18 hour 104 
abstinence from coffee (and other products containing caffeine, including energy drinks), 105 
alcohol, vitamin supplements, products with high levels of vitamin C, polyphenol-rich foods, and 106 
at least 24 hours after strenuous physical activity. All glucose lowering and vasoactive 107 
medication was also withheld on the morning of the measurement (40). We performed all tests 108 
between 8 AM and 4 PM to control for variation in FMD between subjects (4, 14, 15, 38). 109 
 110 
Brachial artery FMD. Measurements were performed by 2 well-experienced sonographers 111 
following a resting period of at least 20 minutes in the supine position. We simultaneously 112 
measured FMD in the right and left brachial arteries according to recent guidelines for 113 
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assessment of FMD as previously described by Thijssen et al (40). For this purpose, both arms 114 
were extended and positioned at an angle of ~80° from the torso. A rapid inflation and deflation 115 
pneumatic cuff (D.E. Hokanson, Bellevue, WA) was positioned on the forearm, immediately 116 
distal to the olecranon process to provide a stimulus to forearm ischemia. A 10-MHz multi-117 
frequency linear array handheld probe, attached to a high-resolution ultrasound machine (T3000; 118 
Terason, Burlington, MA) was then used to image the brachial artery in the distal one third of the 119 
upper arm. When an optimal image was obtained, the probe was held stable and the ultrasound 120 
parameters were set to optimize the longitudinal, B-mode image of the lumen-arterial wall 121 
interface. Settings were identical between all assessments of the FMD. Continuous Doppler 122 
velocity assessments were also obtained using the ultrasound and were collected using the lowest 123 
possible insonation angle (always <60°). Baseline images were recorded for 1 minute after which 124 
the forearm cuff was inflated (>200 mmHg) for 5-minutes. Diameter and flow recordings 125 
resumed 30 sec prior to cuff deflation and continued for 3 minutes thereafter, in accordance with 126 
recent technical specifications (48). 127 
 128 
Forearm skin temperature. During the complete protocol, forearm skin temperature of both 129 
forearms was measured using iButtons® (Maxim Integrated, San Jose, CA). These data were 130 
transferred to a computer and analyzed afterwards. Furthermore, forearm skin temperature was 131 
also measured manually using a standard auricle thermometer before every FMD and every five 132 
minutes during the heating process so that the researcher had a direct indication of the heating 133 
progress.  134 
 135 
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Venous blood. In all individuals, a routine hematochemical check was performed by standard 136 
methods before testing. A venous blood sample was taken at baseline for assessment of fasting 137 
blood lipids, glucose and insulin levels. The subjects’ degree of insulin resistance was assessed 138 
by calculating the HOMA-IR index from fasting glucose and insulin levels. Furthermore, venous 139 
blood was repeatedly taken to assess blood glucose levels at 60, 120 and 150 minutes after 140 
glucose ingestion.  141 
 142 
Brachial Artery Diameter and Blood Flow Analysis  143 
Analysis of brachial artery diameter was performed using custom-designed edge-detection and 144 
wall-tracking software, which is independent of investigator bias. Previous papers contain 145 
detailed descriptions of our analysis approach (48). From synchronized diameter and velocity 146 
data, blood flow (the product of arterial lumen cross- sectional area and Doppler velocity) were 147 
calculated at 30 Hz. Shear rate (an estimate of shear stress without viscosity) was calculated as 4 148 
times mean blood velocity/vessel diameter. Reproducibility of diameter measurements using this 149 
semi-automated software is significantly better than manual methods and reduces observer error 150 
significantly (48). 151 
 152 
Baseline diameter and shear rate were calculated as the mean of data acquired across the 1 153 
minute preceding the cuff inflation period. Following cuff deflation, peak diameter following 154 
cuff deflation was automatically detected according to an algorithm which identified the 155 
maximum bracket of data subsequent to performance of a moving window smoothing function. 156 
This smoothing routine calculates the median value from 100 consecutive samples, before the 157 
window shifts to the next bracket of data which shares 20% overlap with the preceding bracket. 158 
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The maximum value of all the calculated median values is then automatically detected and 159 
chosen to represent the peak of the diameter curve. 160 
 161 
FMD was calculated as the percentage rise of this peak diameter from the preceding baseline 162 
diameter. Calculation of FMD was therefore observer-independent and based on standardized 163 
algorithms applied to data which had undergone automated edge-detection and wall-tracking. 164 
The post-deflation shear rate data, derived from simultaneously acquired velocity and diameter 165 
measures at 30 Hz, was used to calculate the area under the shear rate curve (SRAUC) for data up 166 
to the point of maximal post-deflation diameter (FMD) for each individual. In addition, we 167 
calculated the peak blood flow across a 10-second period after cuff release. Reproducibility of 168 
the brachial artery FMD using this semi-automated software possesses a CV of 6.7-10.5%.  169 
 170 
Statistical analysis 171 
Statistical analyses were performed using SPSS 21.0 software (SPSS, Chicago, IL). Descriptive 172 
statistics are presented as means and standard deviation (SD). All data are reported as LSmeans 173 
(95%CI), unless reported otherwise and was considered statistically significant at P<0.05. 174 
Baseline differences between both arms were examined using a paired Student’s t-test. A two-175 
way repeated measures ANOVA was used to assess difference in blood glucose levels after 176 
glucose ingestion. To examine the impact of hyperglycemia and local heating on outcome 177 
parameters between both groups, we performed a Linear Mixed Model. This model assessed 178 
whether the baseline-adjusted changes in FMD over time (repeated, within-subject variable 179 
‘time’: 0 vs 60 vs 120 vs 150 minutes) were altered by local heating of a forearm (repeated, 180 
within-subject variable ‘arm’: heated vs non-heated), and whether such changes differ between 181 
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groups (between-subject factor ‘group’: controls vs T2DM). When a main effect or interaction-182 
effect was observed, post-hoc tests were performed to identify the differences. Additionally, 183 
FMD data were also analyzed and are presented as covariate-controlled for baseline artery 184 
diameter as this approach is more accurate for scaling changes in artery diameter than simple 185 
percentage change in some cases (2). 186 
 187 
 188 
RESULTS 189 
Baseline characteristics are described in Table 1. T2DM patients had significantly higher glucose 190 
and HOMA-IR compared to controls whereas the control group had significantly higher total- 191 
and LDL cholesterol concentrations. There were no apparent differences in brachial artery 192 
diameter, blood flow, shear rate and FMD between groups at baseline (all comparisons P>0.05). 193 
 194 
Impact of hyperglycemia and heating on blood flow, diameter and glucose 195 
In both groups, ingestion of 75-gr glucose resulted in a significant increase in blood glucose 196 
levels at 60 minutes, which returned towards baseline levels within 150 minutes (“Time” effect, 197 
P<0.001, Figure 1). The increase in blood glucose was significantly larger in T2DM patients 198 
compared to controls (“Time*Group”-interaction effect, P=0.002, Figure 1). Forearm skin 199 
temperature significantly increased in the heated arm during the experiment (“Time” effect, 200 
P<0.001, Table 2) and to a greater extent compared to the non-heated arm (“Time*Arm”-201 
interaction effect, P<0.001). Both T2DM patients and controls demonstrated a comparable 202 
change in skin temperature across time in both arms (“Time*Arm*Group”-interaction effect, 203 
P=0.09).  204 
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 205 
Similar to skin temperature, brachial artery blood flow and shear rate significantly increased in 206 
the heated arm during the experiment (both: “Time” effect, P<0.001) (Figure 2A-B) and to a 207 
greater extent compared to the non-heated arm (both: “Time*Arm”-interaction effect, P<0.001). 208 
T2DM patients and controls demonstrated a comparable change in blood flow and shear rate 209 
across time in both arms (“Time*Arm*Group”-interaction effect, P=0.15 and 0.25, respectively). 210 
In both groups, post hoc analyses indicated a significant increase in blood flow and shear rate at 211 
60 minutes in the heated arm which returned to baseline within 150 minutes. The increase in 212 
blood flow and shear rate at 60 minutes was significantly greater in the controls compared to the 213 
T2DM patients (both P<0.05). Baseline brachial artery diameter did not change during the 214 
experiment and differed neither between arms nor healthy controls and T2DM patients (Table 2).  215 
 216 
Impact of hyperglycemia and heating on brachial artery FMD 217 
A significant Time*Arm-interaction was found (P=0.01). Post hoc analyses indicated that 218 
hyperglycemia induced a significant decrease in FMD in the non-heated arm of 1.4% at 60 219 
minutes (P<0.05). In contrast, the heated arm demonstrated an increase in FMD of 1.5% and 220 
1.3% at 60 and 150 minutes, respectively, despite the presence of hyperglycemia (P<0.05). The 221 
difference in FMD between the heated and non-heated arms was statistically significant at 60, 222 
120 and 150 minutes (P<0.05, Figure 3). When comparing the responses between controls and 223 
T2DM patients, we found no time*arm*group-interaction effect (Figure 3). These outcomes 224 
were reinforced when we repeated our analyses using the absolute (mm) or allometrically scaled 225 
FMD (Table 3). No changes across time or differences between arms or groups were evident for 226 
baseline diameter (Table 2) or shear rate area-under-the-curve (Table 3). 227 
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 228 
DISCUSSION 229 
The aim of this study was to examine whether non-metabolically driven increases in blood flow 230 
and shear rate (through heating of the skin) protects the hyperglycemia-mediated decrease in 231 
endothelial function in healthy subjects and patients with type 2 diabetes mellitus. For this 232 
purpose, we performed bilateral assessment of brachial artery endothelial function which enabled 233 
us to simultaneously study the effects of both a systemic challenge (i.e. hyperglycemia) and a 234 
local intervention (i.e. increased blood flow through unilateral heating). This provides a number 235 
of observations. First, we confirmed previous observations (1, 16, 17, 33, 43, 47) that 236 
hyperglycemia, induced by a 75-gr glucose load, leads to a transient decline in brachial artery 237 
endothelial function. Secondly, local heating of a forearm leads to a marked increase in blood 238 
flow and shear rate, which effectively prevented the hyperglycemia-induced decline in brachial 239 
artery endothelial function. Third, the ability of increases in blood flow and shear rate to prevent 240 
brachial artery endothelial dysfunction after hyperglycemia is similarly present in healthy 241 
middle-aged controls and type 2 diabetes mellitus patients. Taken together, these data suggest 242 
that elevation in blood flow or shear rate can prevent the hyperglycemia-induced decline in 243 
conduit artery endothelial function which typically occurs after a meal. 244 
 245 
Hyperglycemia may affect endothelial function via different pathways. NO bioavailability is 246 
decreased through inhibition of eNOS and increased production of reactive oxygen species 247 
(ROS). Moreover, hyperglycemia may increase production of vasoconstrictor prostanoids such 248 
as prostaglandin H2 and thromboxane A2 (3, 36). Transient damage to the endothelial glycocalyx 249 
may also occur. This luminal surface layer serves as a mechanosensor of shear stress to mediate 250 
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shear-induced release of NO (17, 29). Consequently, a decline in (partly NO-mediated) 251 
endothelial function is observed after a meal or glucose load in healthy volunteers (1, 26, 43), 252 
with some suggestion of an exaggerated impairment in T2DM patients (6, 16). 253 
 254 
Mechanistic work from Hambrecht and coworkers revealed that increases in shear stress, for 255 
example through exercise (11), can improve NO-mediated vasodilator function, increases eNOS 256 
expression and endothelial content of phospho-eNOSSer1177, Akt, and phospho-Akt. Other 257 
mechanistic work demonstrated that elevation in shear also down-regulates expression of 258 
vasoconstrictors, adhesion molecules and coagulation factors (12). Based on this mechanistic 259 
work, we hypothesized that elevation in shear may attenuate or prevent the hyperglycemia-260 
induced decrease in FMD. After successfully increasing blood flow and shear rate in the heated 261 
arm, we confirmed our hypothesis in that FMD in the heated arm showed no decrease. In fact, a 262 
significant increase was observed, which may be explained by the marked increases in blood 263 
flow during the heating intervention. Previous studies also found that (local) heating can acutely 264 
and chronically increase brachial artery FMD% (27, 42). In addition to the effects of shear 265 
rate, sympathetic- and sensory nerve activity play a major role in vasodilatory responses to 266 
local heat in the skin (7, 13). We cannot exclude that these responses in the skin could also 267 
have affected our observations in the brachial artery. Taken together, our observations 268 
suggest that local heat-induced increases in shear stress protect the endothelial function under 269 
hyperglycemic conditions.  270 
 271 
Our study also allowed for the comparison between healthy volunteers and patients with T2DM. 272 
The significantly larger increase in blood glucose levels after 75-gr glucose fits with the presence 273 
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of insulin resistance in the diabetic patients. Despite a substantially larger increase in blood 274 
glucose in the T2DM patients, the attenuation in FMD in the non-heated arm was similar to that 275 
in the healthy controls. We also found no correlation between changes in blood glucose and 276 
FMD (data not shown), which is in agreement with two earlier studies in healthy subjects (1, 43). 277 
Kawano et al. did however report a significant negative correlation between plasma glucose and 278 
FMD, which may be due to the larger sample size and the inclusion of untreated T2DM patients 279 
(16).  280 
 281 
Additionally, heating resulted in comparable increases in FMD between the two groups. 282 
Therefore, our results suggest that the ability of increases in shear to prevent hyperglycemia-283 
induced endothelial dysfunction is similarly present in T2DM patients and healthy, age-matched 284 
controls. It is however interesting to note that the change in blood flow in response to heating 285 
was less pronounced in our group of diabetic patients compared to the healthy controls. This 286 
could indicate that decreased reactivity of resistance vessels and skin microcirculation is already 287 
present in type 2 diabetics before overt changes in conduit artery endothelial function occur. This 288 
observation however should be interpreted with caution since a statistically significant group 289 
effect was not evident in our main analysis. A subsequent sub-group analysis on data from the 290 
heated arm did indicate a significant time*group interaction at T = 60 minutes for both blood 291 
flow and shear rate though (P=0.05 and 0.03 respectively, data not shown). This finding is also 292 
supported by data from other groups who have demonstrated that diabetics have impaired skin 293 
blood flow responses to both local (30, 31) and whole body heating (37). Moreover, impaired 294 
muscle blood flow responses to exercise stimuli in diabetics compared to healthy controls have 295 
also been demonstrated in a number of studies (5, 18, 21). 296 
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 297 
An unexpected finding in our study is that control subjects and T2DM patients reveal no 298 
difference in baseline brachial artery FMD. Although it is generally accepted that T2DM 299 
patients demonstrate lower FMD compared to healthy peers (24, 25), this is not a universal 300 
finding (34, 35). One potential explanation for our finding is that T2DM patients received 301 
optimal pharmacological therapy, including statins (60%) and metformin (80%). These 302 
drugs are associated with improvements in brachial artery FMD (32, 49) and may, 303 
therefore, contribute to the lack of difference in FMD between groups, despite all 304 
medication being withheld on the morning of the measurement. Nonetheless, it is important 305 
to emphasize that both groups demonstrated distinct responses to the heat stimulus. 306 
 307 
Limitations: A potential limitation of our study is that we did not examine endothelium-308 
independent vasodilation. Due to the prolonged effects of glyceryl trinitrate (unpublished 309 
data), including repeated measurements of endothelium-independent dilation would 310 
importantly compromised our study design and outcomes. However previous studies have 311 
found no indication that acute heating or hyperglycemia directly affect vascular smooth muscle 312 
cell reactivity (19, 27). Our study set-up did not allow us to explore specific mechanisms, 313 
such as the evaluation of NO metabolites, to better understand the underlying mechanisms 314 
of our findings. Another potential limitation relates to our method of heating. We employed a 315 
simple setup involving directed hot air. This inadvertently caused a small increase in ambient- 316 
and skin temperature of the control arm (Table 2). As a result small (non-significant) increases in 317 
blood flow and shear rate were evident in the non-heated arm (Figure 2). Therefore, although a 318 
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reduction FMD was still evident in the non-heated arm, it may have been attenuated to a small 319 
extent. 320 
 321 
Clinical relevance: A potential clinical relevance of our findings relates to the suggestion that 322 
(repeated) exposure to transient periods of endothelial dysfunction contributes to the 323 
development of atherosclerosis. Although speculative, prevention or attenuation of endothelial 324 
dysfunction during hyperglycemia seems a potential target. Our observations suggest that non-325 
metabolically driven elevations in shear may be of use to prevent the presence to endothelial 326 
dysfunction. Similarly, (high-intensity) exercise is demonstrated to prevent the post-prandial 327 
decrease in endothelial function (45). As exercise is a strong stimulus for elevation in blood flow 328 
(41), our observations warrant future studies to explore whether the immediate benefits of 329 
physical activity or exercise to prevent post-prandial endothelial dysfunction relate to shear 330 
stress-mediated mechanisms, and may contribute to preservation of endothelial function in 331 
diabetic patients. 332 
 333 
In conclusion, post-prandial hyperglycemia resulted in a transient impairment in brachial artery 334 
FMD in healthy subjects and type 2 diabetics, whilst a heating induced increase in brachial artery 335 
blood flow and shear rate countered the impairment in FMD. Therefore, our data suggest that 336 
that interventions which are aimed at elevating blood flow or shear rate can prevent the 337 
hyperglycemia-induced decline in conduit artery endothelial function which typically occurs 338 
after a meal. 339 
 340 
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FIGURE CAPTIONS 509 
FIGURE 1. Blood glucose levels before (0) and after 75-gr oral glucose (60, 120 and 150 510 
minutes) in patients with type 2 diabetes (n=10, diamonds) and healthy, age-matched 511 
controls (n=10, circles). P-values refer to a two-way ANOVA with ‘group’ (diabetic vs 512 
control) and ‘time’ (0, 60, 120 and 150 minutes) as fixed effects and subject as random 513 
effect. Data are presented as LSmeans ± SE corrected for baseline.*Post-hoc 514 
significantly different from baseline at P<0.05. †Post-hoc significantly different from 515 
control group at P<0.05 516 
 517 
FIGURE 2. Brachial artery blood flow (A) and shear rate (B) before (0) and after 75-gr oral 518 
glucose (60, 120 and 150 minutes) in the control arm (solid symbols) and the heated 519 
arm (open symbols) in patients with type 2 diabetes (n=10, diamonds) and healthy, 520 
age-matched controls (n=10, circles). P-values refer to a linear mixed model to assess 521 
whether the change in blood flow and shear rate during the experiment (‘Time’) 522 
differed between the heated and non-heated arm (‘Arm’) and/or between controls and 523 
type 2 diabetes patients (‘Group’). Data are presented as LSmeans ± SE corrected for 524 
baseline. *Post-hoc significantly different from baseline at P<0.05. 525 
 526 
FIGURE 3. Brachial artery flow mediated dilation (FMD) before (0) and after 75-gr oral 527 
glucose (60, 120 and 150 minutes) in the control arm (solid symbol) and the heated 528 
arm (open symbol) in patients with type 2 diabetes (n=10, diamonds) and healthy, 529 
age-matched controls (n=10, circles). P-values refer to a linear mixed model to assess 530 
whether the change in FMD during the experiment (‘Time’) differed between the 531 
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heated and non-heated arm (‘Arm’) and/or between controls and type 2 diabetes 532 
patients (‘Group’). Data are presented as LSmeans ± SE corrected for baseline. *Post-533 
hoc significantly different from baseline at P<0.05. 534 
  535 
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Table 1. Subject characteristics from patients with type 2 diabetes (n=10) and healthy, age-536 
matched controls (n=10). P-value refers to an unpaired Student’s t-test. Data are presented as 537 
mean ± SD. 538 
 Controls T2DM  
Characteristics Mean ± SD  Mean ± SD  P-value 
Age (years)  57 ± 9  63 ± 6  0.14 
Height (cm) 178 ± 6  176 ± 7  0.43 
Weight (Kg) 85 ± 10  90 ± 13  0.35 
Body Mass Index (Kg/m2) 26.7 ± 3.6  29.0 ± 3.6  0.16 
Systolic BP 132.4 ± 14 138.2 ± 17.3 0.42 
Diastolic BP 79.0 ± 6.2 79.9 ± 6.7 0.77 
Total Cholesterol (mmol/L) 6.2 ± 1.1  4.7 ± 1.1  <0.01 
High-density lipoproteins (mmol/L) 1.5 ± 0.2  1.3 ± 0.3  0.07 
Low-density lipoproteins (mmol/L) 4.0 ± 1.0  2.7 ± 1.0  <0.01 
Triglycerides (mmol/L) 1.9 ± 0.9  2.0 ± 0.8  0.85 
Insulin (mmol/L)† 6.0 ± 6.1  10.3 ± 5.7  0.13 
Glucose (mmol/L) 4.9 ± 0.5  7.1 ± 1.0 <0.001 
HOMA-IR† 1.4 ± 1.6  3.3 ± 1.9  0.04 
† One erroneous measurement from the control group was excluded 539 
 540 
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Table 2. Brachial artery diameter and skin temperature before (0) and 60, 120 and 150 minutes after 75-gr oral glucose load  in the 541 
non-heated control arm and the heated arm in patients with type 2 diabetes (n=10) and healthy, age-matched controls (n=10). Data are 542 
presented as LSmeans (95% CI) corrected for baseline (time = 0). 543 
  Time Linear Mixed Model 
Baseline D (mm) 0 60 120 150 Time Arm Time*Arm 
Time*Arm
*Group 
Controls Heated 4.3 (4.2; 4.5) 4.6 (4.4; 4.7) 4.6 (4.4; 4.7) 4.5 (4.3; 4.6) 
0.09 0.88 0.85 0.61 
 Non-heated 4.3 (4.2; 4.5) 4.5 (4.3; 4.6) 4.4 (4.2; 4.6) 4.4 (4.3; 4.6) 
T2DM Heated 4.3 (4.2; 4.5) 4.3 (4.2; 4.5) 4.4 (4.2; 4.6) 4.4 (4.2; 4.5) 
 Non-heated 4.4 (4.2; 4.5) 4.4 (4.2; 4.6) 4.5 (4.3; 4.6) 4.4 (4.3; 4.6) 
Temperature (ºC)         
Controls Heated 31.8 (31.0; 32.5) 41.1 (40.3; 41.9)*† 33.8 (33.0; 34.6)* 32.9 (32.1; 33.7)* 
<0.001 <0.001 <0.001 0.09 
 Non-heated 31.6 (30.9; 32.4) 32.9 (32.1; 33.6)* 33.1(32.3; 33.8)* 32.5 (31.8; 33.3) 
T2DM Heated 31.9 (31.2; 32.6) 39.4 (38.7; 40.2) *† 33.1 (32.4; 33.8)* 32.7 (32.0; 33.5) 
 Non-heated 31.8 (31.1; 32.5) 33.4 (32.7; 34.2)* 32.6 (31.8; 33.3) 32.3 (31.5; 33.0) 
D; diameter. *Post-hoc significantly different from baseline at P<0.05 (paired t-test). †Post-hoc significantly different from non-heated 544 
arm at P<0.05 (unpaired t-test) 545 
  546 
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Table 3. Brachial artery flow-mediated dilation before (0) and after 75-gr oral glucose (60, 120 and 150 minutes) in the non-heated 547 
control arm and the heated arm in patients with type 2 diabetes (n=10) and healthy, age-matched controls (n=10). Data are presented 548 
as LSmeans (95% CI) corrected for baseline (time = 0). 549 
  Time Linear Mixed Model 
FMD (mm) 0 60 120 150 Time Arm Time*Arm 
Time*Arm
*Group 
Controls Heated 0.20 (0.14; 0.25) 0.25 (0.20; 0.31)† 0.24 (0.18; 0.30) 0.26 (0.20; 0.31) 
0.85 0.01 0.01 0.88 
 Non-heated 0.19 (0.14; 0.25) 0.16 (0.10; 0.22) 0.17 (0.11; 0.23) 0.18 (0.12; 0.24) 
T2DM Heated 0.18 (0.12; 0.24) 0.26 (0.20; 0.32)*† 0.21 (0.15; 0.27) 0.23 (0.17; 0.29) 
 Non-heated 0.22 (0.16; 0.28) 0.15 (0.09; 0.21)* 0.15 (0.09; 0.21) 0.16 (0.10; 0.22) 
Scaled FMD (%)         
Controls Heated 4.0 (2.7; 5.3) 6.1 (4.8; 7.4)*† 5.5 (4.1; 6.8) 5.6 (4.3; 6.9)* 
0.65 0.09 0.02 0.91 
 Non-heated 4.3 (3.0; 5.6) 3.7 (2.4; 5.0) 3.8 (2.6; 5.1) 4.1 (2.8; 5.4) 
T2DM Heated 3.7 (2.5; 5.1) 5.4 (4.0; 6.7)* 4.3 (2.9; 5.7) 5.1 (3.8; 6.4) 
 Non-heated 5.4 (4.0; 6.7) 3.9 (2.6; 5.2) 3.9 (2.6; 5.3) 4.0 (2.6; 5.3) 
SRAUC (×103 s-1)         
Controls Heated 27.7 (22.6; 32.9) 30.0 (24.9; 35.1) 26.3 (21.1; 31.4) 22.6 (17.5; 27.7) 
0.1 0.09 0.82 0.82 
 Non-heated 25.8 (20.7; 30.9) 25.7 (20.6; 30.8) 22.6 (17.5; 27.7) 22.9 (17.8; 28.0) 
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T2DM Heated 25.9 (20.8; 31.0) 29.3 (24.2; 34.4) 27.7 (22.6; 32.8) 27.1 (22.0; 32.2) 
 Non-heated 24.6 (19.5; 29.7) 27.0 (21.9; 32.1) 22.6 (17.5; 27.7) 23.4 (18.3; 28.5) 
FMD; Flow Mediated Dilation. SRAUC; Shear Rate Area Under the Curve. *Post hoc significantly different from baseline at P<0.05 550 
(paired t-test). †Post-hoc significantly different from non-heated arm at P<0.05 (unpaired t-test)551 
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